BOUTROS, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 1.684
AS - Asia 370
NA - Nord America 216
SA - Sud America 31
AF - Africa 10
OC - Oceania 2
Totale 2.313
Nazione #
IT - Italia 1.595
US - Stati Uniti d'America 210
SG - Singapore 138
CN - Cina 92
VN - Vietnam 85
BR - Brasile 23
FI - Finlandia 22
FR - Francia 20
HK - Hong Kong 20
DE - Germania 14
JP - Giappone 9
CH - Svizzera 5
ES - Italia 5
GB - Regno Unito 5
BD - Bangladesh 4
ZA - Sudafrica 4
RO - Romania 3
RU - Federazione Russa 3
SA - Arabia Saudita 3
AO - Angola 2
AT - Austria 2
AU - Australia 2
CA - Canada 2
CL - Cile 2
CO - Colombia 2
EG - Egitto 2
HR - Croazia 2
ID - Indonesia 2
IL - Israele 2
IQ - Iraq 2
PL - Polonia 2
SI - Slovenia 2
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GT - Guatemala 1
IE - Irlanda 1
IN - India 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MX - Messico 1
MY - Malesia 1
NI - Nicaragua 1
NL - Olanda 1
OM - Oman 1
PH - Filippine 1
PY - Paraguay 1
SE - Svezia 1
SR - Suriname 1
TH - Thailandia 1
TN - Tunisia 1
TR - Turchia 1
UA - Ucraina 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 2.313
Città #
Genoa 1.096
Vado Ligure 260
Genova 128
Ashburn 65
Singapore 64
Rapallo 62
San Jose 58
Ho Chi Minh City 31
Council Bluffs 24
Helsinki 21
Hong Kong 18
Lauterbourg 17
Hanoi 16
Beijing 12
Frankfurt am Main 10
Santa Clara 8
Naples 7
Tokyo 6
Bordighera 5
Da Nang 5
New York 5
Atlanta 4
Haiphong 4
Milan 4
Rome 4
Can Tho 3
Johannesburg 3
Orem 3
São Paulo 3
Zurich 3
Biên Hòa 2
Bắc Giang 2
Cairo 2
City of London 2
Dietikon 2
Florence 2
Goiânia 2
Ljubljana 2
London 2
Luanda 2
Modena 2
Pistoia 2
Shenzhen 2
Suzhou 2
Tel Aviv 2
Tianjin 2
Turin 2
Albignasego 1
Almaty 1
Amsterdam 1
Baghdad 1
Baku 1
Bandar Seri Begawan 1
Bandung 1
Bareggio 1
Barra Mansa 1
Belo Campo 1
Belo Horizonte 1
Belton 1
Boston 1
Brugherio 1
Bucaramanga 1
Buffalo 1
Bình Phước 1
Caicó 1
Cape Town 1
Caxias do Sul 1
Chennai 1
Chicago 1
Curitiba 1
Dallas 1
Dammam 1
Des Moines 1
Dublin 1
Espumoso 1
Giessen 1
Gobernador Virasoro 1
Guangzhou 1
Guarulhos 1
Hahira 1
Hawthorne 1
Heilbronn 1
Honolulu 1
Hua Hin 1
Hải Dương 1
Istanbul 1
Kuala Lumpur 1
Kuwait City 1
Kyiv 1
La Pintana 1
Lappeenranta 1
Long An 1
Long Xuyen 1
Madrid 1
Mairiporã 1
Managua 1
Marbella 1
Maturín 1
Medeiros Neto 1
Medina 1
Totale 2.036
Nome #
Guidelines for the diagnosis and treatment of basal cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology 307
Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4+ tumor infiltrating lymphocytes and their in situ localization 154
Current State of Target Treatment in BRAF Mutated Melanoma 152
Activity and safety of first-line treatments for advanced melanoma: A network meta-analysis 135
Immune Checkpoint Inhibitors-Related Myastenia Gravis, Myocarditis and Myositis: A Systematic Review of Cases 132
Case Report: Immune-Related Toxicity During Adjuvant Treatment With BRAF Plus MEK Inhibitors in a Melanoma Patient 114
Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature 105
Association between PD-1 single nucleotide gene variants and the risk of metastatic melanoma 101
Primary endobronchial melanoma: a case report and clinical management indications 94
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications 88
Enhanced patient journey associated with improved overall survival in colon cancer patients: A study by the Ligurian Oncology Network 77
Early discontinuation of cemiplimab in patients with advanced cutaneous squamous cell carcinoma 76
Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysis 75
Treatment beyond progression with anti-PD-1/PD-L1 based regimens in advanced solid tumors: a systematic review 73
Case report: Pembrolizumab plus Axitinib related hypothyroid myopathy in two kidney cancer patients 73
Neoadjuvant treatments in patients with high-risk resectable stage III/IV melanoma 71
The predictive and prognostic role of single nucleotide gene variants of PD-1 and PD-L1 in patients with advanced melanoma treated with PD-1 inhibitors 65
Merkel Cell Carcinoma: An Immunotherapy Fairy-Tale? 65
Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma 63
Tisotumab vedotin 62
Immune-checkpoint inhibitors for the treatment of metastatic melanoma: a model of cancer immunotherapy 56
How to protect ovarian function before and during chemotherapy? 55
Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology 54
Identification of prognostic liquid biopsy biomarkers in patients with cutaneous squamous cell carcinoma treated with cemiplimab 45
The adjuvant treatment revolution for high-risk melanoma patients 44
Immune-related osteitis mimicking femoral head osteonecrosis during dual checkpoint blockade: a case report 33
End‑of‑life care in advanced melanoma: a retrospective cohort study from an Italian comprehensive cancer center 7
Molecular Profiling and Matched Targeted Therapy for Patients With Advanced Melanoma: Results From Part 1 of the MatchMEL Study 6
Prospective tumour mutation burden and neoantigen profiling predicts immunotherapy response in metastatic melanoma 5
Dissecting the Spectrum of Rare BRAF Mutations in Melanoma: A Nation-Wide Study by the Italian Melanoma Intergroup (IMI) 3
Totale 2.390
Categoria #
all - tutte 8.178
article - articoli 8.178
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.356


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113 0 0 0 0 0 0 0 0 0 6 4 3
2021/202253 2 0 0 4 3 3 0 12 7 10 1 11
2022/202382 8 8 1 5 13 4 0 4 10 3 25 1
2023/2024124 1 1 5 17 8 15 4 12 8 17 6 30
2024/2025897 24 35 19 61 84 58 47 101 28 34 86 320
2025/20261.149 141 37 105 110 144 71 152 101 152 136 0 0
Totale 2.390